Alan Roloff

Alan Roloff, Ph.D., is a highly experienced Principal Medical Science Liaison currently at Avidity Biosciences, Inc. since February 2025, with a strong background in neurodegenerative therapeutics and cannabinoid neurology. Prior roles include serving as Principal Medical Science Liaison at Alector, and Senior Medical Science Liaison at Greenwich Biosciences, alongside extensive experience at notable companies such as Bristol-Myers Squibb, Celgene, and Biogen. Alan's expertise encompasses clinical trial site management, resource development, collaboration with external principal investigators, and leading significant congress initiatives. Academic credentials include a Ph.D. in Pharmacology from the University of Minnesota and a BS in Biochemistry/Molecular Biology from the University of Wisconsin-Eau Claire.